| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/10/2008 | EP1965829A1 Alternative oxidase and uses thereof |
| 09/10/2008 | EP1965762A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 09/10/2008 | EP1651247B1 Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1381629B1 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1062232B1 Molecules that home to various selected organs or tissues |
| 09/10/2008 | EP1060247B1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 09/10/2008 | EP0956039B1 IL-11 signalling for enhancing fertility |
| 09/10/2008 | EP0871376B1 Use of locally administered lysine for enhancing vascular fonction |
| 09/10/2008 | CN101263230A Pharmaceutical compositions for delivery of ribonucleic acid to a cell |
| 09/10/2008 | CN101260384A Polynucleotide containing ubiquitous chromatin-opening element (UCOE) |
| 09/10/2008 | CN101260152A Method for down-regulating Osteoprotegerin ligand activity |
| 09/10/2008 | CN101259289A Methods and compositions for therapeutic use of RNA interference |
| 09/10/2008 | CN101259288A Preparation of prolactin genetic engineering vaccine |
| 09/10/2008 | CN100417727C Medical preparations for treatment of alpha-galactosidase A deficiency |
| 09/10/2008 | CN100417419C Composition and method to alter lean body mass and bone properties in a subject |
| 09/10/2008 | CN100417418C Nucleic acid-containing complex |
| 09/10/2008 | CN100417413C Novel use of thymosin alpha protogene |
| 09/09/2008 | US7423142 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent |
| 09/09/2008 | US7423138 Antiproliferative agents; anticancer agents; urogenital systems; insertion into cells |
| 09/09/2008 | US7423137 Nucleic acids encoding recombinant 56 and 82 kDa antigens from gametocytes of Eimeria maxima and their uses |
| 09/09/2008 | US7423135 Expression vector comprising rodent regulatory sequences for use as gene expression control tools in genetic engineering |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 09/09/2008 | US7423016 Genetic engineering; inducting immunology response |
| 09/09/2008 | US7422906 Apoptosis-inducing gene and utilization of the same |
| 09/09/2008 | US7422896 Compositions for DNA mediated gene silencing |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422749 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 09/09/2008 | US7422743 Using DCRS5 (SEQ ID NOs: 1 or 2) or p19 (SEQ ID NOs: 5 or 6) cytokine receptors agonist or antagonist to treat rheumatoid arthritis, asthma, allergies, chronic obstructive pulmonary disorder, interstitial lung disorder, inflammatory bowel disorder, inflammatory skin disorder |
| 09/09/2008 | US7422741 VEGFR-3 fusion proteins |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | US7422574 Microseeding device for gene delivery by microneedle injection |
| 09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/04/2008 | WO2008106646A2 Methods and formulations for topical gene therapy |
| 09/04/2008 | WO2008106644A2 Treatment of diseases characterized by inflammation |
| 09/04/2008 | WO2008106507A2 Mdm2/mdmx inhibitor peptide |
| 09/04/2008 | WO2008105925A2 COMPOUNDS AND METHODS FOR MODULATING β-CATENIN/SMAD-7 INTERACTIONS |
| 09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
| 09/04/2008 | WO2008105476A1 Circadian rhythm genes and clock motif |
| 09/04/2008 | WO2008104979A2 Nuclear targeting sequences |
| 09/04/2008 | WO2008104978A2 Novel sirna structures |
| 09/04/2008 | WO2008104974A2 Composition and methods for modulating cell proliferation and cell death |
| 09/04/2008 | WO2008073634A3 Compositions and methods for detecting and treating endothelial dysfunction |
| 09/04/2008 | WO2008058225A3 Methods and compositions for treating cancer using bcl-2 antisense oligomers, tyrosine kinase inhibitors, and chemotherapeutic agents |
| 09/04/2008 | WO2007134132A8 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 09/04/2008 | WO2007130060A3 Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues |
| 09/04/2008 | US20080215032 Minimizing Metal Toxicity During Electroporation Enhanced Delivery of Polynucleotides |
| 09/04/2008 | US20080214799 Fetal gene expression network/profile for identifying gene products which confer apoptosis resistant and interleukin-6 repressive phenotypes; treating and/or preventing ischemic reperfusion injuries |
| 09/04/2008 | US20080214486 RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 09/04/2008 | US20080214483 Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-beta (TGF-beta) |
| 09/04/2008 | US20080213888 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 09/04/2008 | US20080213884 Transgenic cell expressing vector comprising tissue specific regulatory sequences; tissue target gene expression |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213786 Using lectin modulators as treatments for cell proliferative and inflammatory disorders |
| 09/04/2008 | US20080213426 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213309 Multi-antigenic alphavirus replicon particles and methods |
| 09/04/2008 | US20080213306 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213264 Immunogens; vaccines; fusion proteins |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213248 Methods and Systems for Treating Asthma and Other Respiratory Diseases |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213223 Using virus-ligand complex to specifically bind and target cancer cells for destruction; gene therapy |
| 09/04/2008 | US20080213222 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213220 Adenovirus vector comprising progression elevated gene-3 (PEG-3) regulatory sequences and E1A tumor suppressor gene for use in targeted destruction of cancer cells; antiproliferative agents |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | US20080213182 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | DE102007008890A1 Nukleinsäure, die für eine pflanzliche Adenosin-Nukleosidase kodiert Nucleic acid encoding a plant adenosine nucleosidase |
| 09/04/2008 | CA2699418A1 Composition and methods for modulating cell proliferation and cell death |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964852A1 Anti-ilt7 antibody |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1963861A1 Rna helicase as marker for rare tumours |
| 09/03/2008 | EP1963551A1 Markers for memory t cells and uses thereof |
| 09/03/2008 | EP1963514A2 Methods for phototransfecting nucleic acid into live cells |
| 09/03/2008 | EP1962889A1 Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof |
| 09/03/2008 | EP1476468B1 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 09/03/2008 | EP1463520B1 Immunisation against chlamydia trachomatis |
| 09/03/2008 | EP1431347B1 Composition containing fine particles as carriers for biologically active substance and method for preparing these |
| 09/03/2008 | EP1426443B1 Human bmcc1 gene |
| 09/03/2008 | EP1291429B1 Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 09/03/2008 | EP1180159B1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | EP1112371B1 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 09/03/2008 | EP0950098B1 Stable expression of triple helical proteins |
| 09/03/2008 | EP0789575B1 Peripheral nervous system specific sodium channels, dna encoding therefor, drug screening, and methods of making and using thereof |
| 09/03/2008 | EP0781331B1 Improvements in or relating to binding proteins for recognition of dna |
| 09/03/2008 | CN101255442A LMP-1 recombinant gland related viral vectors as well as construction method and uses thereof |